Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 ml/min/1.73 m2) European renal best practice
Journal Title: Нирки - Year 2017, Vol 6, Issue 2
Abstract
.
Authors and Affiliations
M. D. Ivanova, D. D. Ivanov
Keywords
Related Articles
- EP ID EP208920
- DOI 10.22141/2307-1257.6.2.2017.102790
- Views 80
- Downloads 0
Drug treatment of urolithiasis using citrate therapy
Urolithiasis - disease, morphological substrate of which is the formation of stones in the urinary tract and related changes in the urinary tract. The disease is characterized by its prevalence and a variety of etiologic...
Lupus Nephritis: Experience of Treatment with Rituximab (Clinical Observation)
.
Influence of Aflazin® on the Adhesive Properties of Microorganisms — Pathogens of Catheter-Related Infections
The influence of Aflazin® (UTIRose™) and separately its combination with levofloxacin on the adhesive properties of opportunistic pathogens has been studied. It is found that addition of the active substance of Aflazin®...
Analysis of the factors of survival to renal replacement therapy in patients with chronic kidney disease
Background. The relationship between chronic kidney disease (CKD) and cardiovascular diseases is important and is characterized by the presence of numerous adverse factors compared with patients with cardiovascular disea...
Determining the level of subpopulations of peripheral blood lymphocytes for the diagnosis of chronic renal allograft rejection
Background. One of the main causes of renal allografts (RA) failure in the long-term period after transplantation is progressive chronic allograft dysfunction (CAD), the cause of which in 20 to 60 % of cases is chronic r...